WASHINGTON (November 29, 2012)—Public Citizen, a government watchdog group, is calling on the U.S. Food and Drug Administration to re-inspect more than a dozen specialty pharmacies with prior records of violations, in the wake of a recent deadly meningitis outbreak tied to compounded drugs.
Contaminated pain injections from a Massachusetts compounding pharmacy are linked to a fungal meningitis outbreak that killed 36 people and sickened more than 500, according to federal health officials.
In a letter to the FDA sent Thursday, Public Citizen asks the agency to revisit 16 compounding pharmacies that received warning letters from the agency between 2003 and 2009.
Compounding pharmacies traditionally mix customized medications based on doctors' instructions, turning out a small number of specialized products for patients with unusual medical needs.
However, some pharmacies have grown into much larger businesses in recent years.